CDC123 Antibody

What is CDC123 and what are its main functions?

CDC123, also known as C10orf7, D123, Translation initiation factor eIF2 assembly protein, or Cell division cycle protein 123 homolog, functions as an ATP-dependent protein-folding chaperone for the eIF2 complex. It binds specifically to the gamma subunit of the eIF2 complex, facilitating the assembly with alpha and beta subunits to form a functional complex . Recent research has identified CDC123 as a key activator of effector-triggered immunity (ETI)-associated translation and defense in plants, where it mediates the assembly of the eIF2 complex during immune responses . In cellular processes, CDC123 appears to influence eIF2γ protein stability, suggesting a regulatory role in translation initiation beyond simple complex assembly .

What types of CDC123 antibodies are available for research applications?

Current research tools include multiple formats of CDC123 antibodies with varying specifications:

These antibodies provide researchers with options for different experimental approaches depending on the target species and application requirements .

What are the standard applications for CDC123 antibodies?

CDC123 antibodies can be utilized in multiple research applications with validated protocols:

• Immunohistochemistry (IHC-P): Particularly effective for paraffin-embedded tissues, with established protocols including antigen retrieval using high-pressure citrate buffer (pH 6.0) treatment. Standard dilutions typically range from 1/100 to 1/500 depending on the specific antibody and tissue type .

• Western Blotting (WB): For protein expression analysis, detecting CDC123 protein (approximately 27-30 kDa) in cell and tissue lysates .

• Immunofluorescence (IF): For subcellular localization studies of CDC123, often used in conjunction with other cellular markers .

• ELISA: For quantitative measurement of CDC123 in solution samples .

The selection of application should be guided by both experimental objectives and the validated applications for each specific antibody as indicated in product documentation .

How does CDC123 function mechanistically in translation initiation?

CDC123 operates through an ATP-dependent mechanism to facilitate eIF2 complex assembly. During cellular stress responses such as effector-triggered immunity (ETI), increased ATP concentration enables CDC123 to effectively mediate the assembly of the eIF2 complex components . Biochemical studies demonstrate that CDC123 specifically binds to the gamma subunit of the eIF2 complex, creating a scaffold that allows proper interaction with alpha and beta subunits .

This ATP-dependency creates a molecular link between cellular energy status and translational regulation. Research using mutant CDC123 (such as the dst7 mutant in plants) shows that in the absence of functional CDC123, increased ATP levels are insufficient to promote eIF2 assembly, indicating that CDC123 is the primary mediator of this process . Additionally, pharmacological inhibition of ATP synthesis by oligomycin A treatment compromises ETI-mediated translational induction in wild-type organisms but not in CDC123 mutants, further confirming this mechanistic relationship .

What are the considerations for choosing between monoclonal and polyclonal CDC123 antibodies?

The decision between monoclonal and polyclonal CDC123 antibodies depends on experimental requirements:

Monoclonal Antibodies (e.g., Mouse 1F8, 3E8, 4B9):

• Advantages: High specificity for a single epitope, minimal batch-to-batch variation, ideal for consistent long-term studies

• Optimal Applications: Precise epitope targeting, protein-protein interaction studies

• Limitations: May have reduced sensitivity due to single epitope recognition, potentially vulnerable to epitope masking in certain applications

Polyclonal Antibodies (e.g., Rabbit polyclonals):

• Advantages: Recognize multiple epitopes, higher sensitivity, more robust against protein denaturation

• Optimal Applications: Western blotting of denatured proteins, detection of low-abundance targets

• Limitations: Batch-to-batch variation, potential for higher background

For critical quantitative comparisons across multiple experiments, monoclonal antibodies provide better consistency. For exploratory or initial detection studies, polyclonal antibodies may offer superior sensitivity. When studying novel post-translational modifications or protein interactions that might mask specific epitopes, using both types in parallel can provide complementary data .

How can CDC123 antibodies be used to investigate its role in translational regulation during immune responses?

Investigating CDC123's role in translational regulation during immune responses requires multi-faceted approaches:

• Polysome Profiling Analysis: CDC123 antibodies can be used in conjunction with polysome profiling to examine changes in the association between CDC123 and translation machinery components. Research has shown that in CDC123 mutants (dst7), there is no significant shift between monosome and polysome fractions during immune responses, indicating CDC123's essential role in translational activation .

• Co-Immunoprecipitation (coIP) Studies: Using CDC123 antibodies for coIP experiments can reveal dynamic interactions with eIF2 complex components during immune activation. Previous studies demonstrate that CDC123 is required for the increased interaction between eIF2α, eIF2β, and eIF2γ during immune responses .

• Protein Stability Analysis: CDC123 antibodies can track changes in eIF2γ protein levels in response to immune stimuli. Data suggests CDC123 affects eIF2γ stability, with CDC123 mutants showing reduced eIF2γ-myc protein levels that exceed the decrease in corresponding mRNA levels .

• SUnSET Assay Integration: Combining CDC123 antibody-based detection with SUnSET (Surface Sensing of Translation) assays can directly measure global translational activity changes during immune responses in relation to CDC123 function .

These methodologies collectively provide mechanistic insights into how CDC123 links ATP availability to translational regulation during immune responses.

What is the optimal protocol for immunohistochemical detection of CDC123 in tissue samples?

For optimal immunohistochemical detection of CDC123 in paraffin-embedded tissues, the following protocol has been validated:

• Sample Preparation:

  • Fix tissue in 10% neutral-buffered formalin (24-48 hours)

  • Process and embed in paraffin following standard procedures

  • Section tissues at 4-6 μm thickness onto positive-charged slides

• Deparaffinization and Rehydration:

  • Heat slides at 60°C for 1 hour

  • Dewax in xylene (3 × 5 minutes)

  • Rehydrate through graded alcohols (100%, 95%, 70%, 50%) to water

• Antigen Retrieval (Critical Step):

  • Perform high-pressure antigen retrieval in citrate buffer (pH 6.0)

  • Alternative: 20 minutes in preheated retrieval buffer at 95-98°C

• Blocking and Primary Antibody Incubation:

  • Block with 10% normal goat serum for 30 minutes at room temperature

  • Dilute CDC123 antibody in 1% BSA solution (typical working dilution: 1/500)

  • Incubate at 4°C overnight in a humidified chamber

• Detection System:

  • Apply biotinylated secondary antibody (30 minutes at room temperature)

  • Develop using avidin-biotin-peroxidase complex and DAB or similar chromogen

  • Counterstain with hematoxylin

• Controls:

  • Include negative controls (omitting primary antibody)

  • Include positive controls (endometrial cancer tissue shows reliable CDC123 expression)

This protocol has been successfully employed to detect CDC123 in human endometrial cancer tissue and can be adapted for other tissue types with appropriate optimization .

How should CDC123 antibodies be validated for experimental use?

Comprehensive validation of CDC123 antibodies should include multiple complementary approaches:

• Specificity Verification:

  • Western Blot Analysis: Confirm single band at expected molecular weight (~27-30 kDa)

  • Peptide Competition Assay: Pre-incubation with immunizing peptide should abolish signal

  • Knockout/Knockdown Controls: Compare antibody signal in CDC123-depleted vs. normal samples

• Application-Specific Validation:

  • Immunohistochemistry: Validate using known positive tissues (e.g., endometrial cancer)

  • Immunofluorescence: Confirm expected subcellular localization pattern

  • IP/Co-IP: Verify ability to pull down CDC123 and known interacting partners

• Cross-Reactivity Assessment:

  • When extending use to non-validated species, perform comparative analysis

  • Evaluate sequence homology between species for the antibody's target region

  • Empirically test at multiple dilutions with appropriate positive/negative controls

• Reproducibility Testing:

  • Test multiple antibody lots if available

  • Document all validation procedures for future reference

  • Consider parallel testing with alternative antibodies targeting different epitopes

This systematic validation approach ensures reliable and reproducible results across experimental applications and minimizes potential artifacts .

What are the recommended protocols for using CDC123 antibodies in co-immunoprecipitation studies?

For effective co-immunoprecipitation (co-IP) studies investigating CDC123 interactions with the eIF2 complex components:

Sample Preparation:

• Harvest cells or tissues and lyse in a non-denaturing buffer containing:

  • 50 mM Tris-HCl (pH 7.4)

  • 150 mM NaCl

  • 1% NP-40 or 0.5% Triton X-100

  • Protease inhibitor cocktail

  • Phosphatase inhibitors (if phosphorylation is relevant)

  • 2-5 mM ATP (critical for CDC123 function studies)

Co-IP Procedure:

• Pre-clear lysate with protein A/G beads (1 hour at 4°C)

• Incubate pre-cleared lysate with CDC123 antibody (4-5 μg per 1 mg protein) overnight at 4°C

• Add protein A/G beads and incubate for 2-4 hours at 4°C

• Wash beads 5-6 times with lysis buffer

• Elute bound proteins by boiling in SDS sample buffer

Analysis:

• Separate eluted proteins by SDS-PAGE

• Transfer to PVDF/nitrocellulose membrane

• Immunoblot for CDC123 and potential interacting partners (eIF2α, eIF2β, eIF2γ)

Controls:

• Input control (5-10% of pre-cleared lysate)

• IgG control (non-specific antibody of same isotype)

• Reverse co-IP (using antibodies against suspected interacting partners)

This protocol has been successfully used to demonstrate CDC123-dependent assembly of the eIF2 complex components during immune responses, revealing that CDC123 is required for increased interaction between eIF2α, eIF2β, and eIF2γ during ETI .

What are common challenges when using CDC123 antibodies and how can they be addressed?

Researchers frequently encounter several challenges when working with CDC123 antibodies that can be systematically addressed:

For challenging applications, consider using epitope-tagged CDC123 expression constructs (CDC123-YFP or CDC123-myc) in conjunction with well-characterized tag antibodies as demonstrated in complementation studies .

How should researchers interpret contradictory results when studying CDC123 with different antibodies?

When faced with contradictory results using different CDC123 antibodies, researchers should implement a systematic analytical approach:

• Epitope Mapping Analysis:

  • Compare the target regions of each antibody (e.g., N-terminal aa 1-100 vs. internal region aa 44-97)

  • Consider whether post-translational modifications might affect epitope accessibility

  • Evaluate if protein interactions could mask specific epitopes

• Experimental Condition Comparison:

  • Analyze buffer compositions across experiments (detergents, salt concentrations)

  • Review fixation methods for potential epitope alteration

  • Examine sample preparation procedures for potential protein modification

• Validation Strategy:

  • Implement knockout/knockdown controls with each antibody

  • Use orthogonal techniques (mass spectrometry, immunoprecipitation followed by Western blotting)

  • Consider specific cellular contexts (ATP levels vary by cellular state, affecting CDC123 function)

• Resolution Approach:

  • Perform side-by-side testing under identical conditions

  • Design experiments targeting functional outcomes (e.g., translational activity measurements)

  • Consult literature for similar contradictions and resolutions

Recent studies have shown that CDC123 function is highly ATP-dependent, which may explain some contradictory observations if ATP levels were not controlled consistently across experiments .

How can CDC123 antibodies be used to analyze changes in translation initiation complex assembly during cellular stress?

To effectively analyze translation initiation complex assembly during cellular stress using CDC123 antibodies:

• Integrated Polysome Profiling Approach:

  • Treat cells with stress inducers (e.g., pathogen effectors, ATP depletion agents)

  • Generate polysome profiles by sucrose gradient fractionation

  • Analyze CDC123 distribution across fractions using validated antibodies

  • Correlate CDC123 localization with eIF2 complex components

• Quantitative Co-IP Time Course:

  • Collect samples at defined intervals after stress induction

  • Perform co-IP using CDC123 antibodies or antibodies against eIF2 components

  • Quantify relative amounts of co-precipitated proteins by Western blotting

  • Generate interaction kinetics profiles for the translation complex components

• Proximity Ligation Assay (PLA):

  • Use CDC123 antibody paired with antibodies against eIF2α, eIF2β, or eIF2γ

  • Visualize and quantify native protein interactions in situ

  • Compare interaction frequencies under normal vs. stress conditions

• Protein Stability Assessment:

  • Implement cycloheximide chase experiments

  • Use CDC123 antibodies to monitor stability of eIF2 complex components

  • Compare degradation rates in wild-type vs. CDC123-depleted conditions

Published research demonstrates that during effector-triggered immunity, CDC123 facilitates increased interaction between eIF2 complex components, and this assembly is correlated with increased ATP levels. In CDC123 mutants, despite normal ATP elevation, the eIF2 complex fails to properly assemble, indicating CDC123's essential mediating role between ATP sensing and translation initiation .

What are emerging applications of CDC123 antibodies in studying translational regulation?

CDC123 antibodies are poised to contribute to several emerging research areas in translational regulation:

• Spatiotemporal Dynamics Analysis:

  • Super-resolution microscopy combined with CDC123 antibodies can reveal subcellular localization changes during different phases of translation initiation

  • Live-cell imaging using fluorescently-labeled CDC123 antibody fragments can track dynamic changes in real-time

  • Correlation with sites of active translation using techniques like ribopuromycylation

• Systems Biology Integration:

  • Proteome-wide interaction mapping using CDC123 antibodies for immunoprecipitation followed by mass spectrometry

  • Integration with translatomic data to create comprehensive models of translation regulation

  • Network analysis to position CDC123 within the broader translation regulation system

• Stress Response Pathway Mapping:

  • Using CDC123 antibodies in conjunction with phospho-specific antibodies against stress-responsive translation factors

  • Investigation of CDC123's role in different cellular stress responses beyond immune activation

  • Comparative analysis across different organisms to identify conserved and divergent functions

• Therapeutic Target Validation:

  • Evaluation of CDC123 as a potential target in diseases with dysregulated translation

  • Development of function-blocking antibodies against specific CDC123 functional domains

  • Correlation of CDC123 expression/activity with disease progression

Recent findings in plant immunity research have established CDC123 as a key mediator linking ATP availability to translational reprogramming during immune responses . This connection between energy metabolism and translation regulation represents a promising area for further investigation across biological systems.

How can CDC123 antibodies contribute to our understanding of eIF2 complex regulation across different biological contexts?

CDC123 antibodies offer unique opportunities to explore eIF2 complex regulation across diverse biological contexts:

• Comparative Immunology Studies:

  • Use CDC123 antibodies to analyze eIF2 complex assembly during immune responses in different organisms

  • Compare translational reprogramming mechanisms between plant ETI and animal innate immunity

  • Investigate potential parallels between plant cell death and animal pyroptosis at the translational level

• Developmental Biology Applications:

  • Track CDC123-mediated eIF2 complex assembly during different developmental stages

  • Correlate with stage-specific translational programs

  • Investigate tissue-specific regulation of translation initiation

• Pathological Condition Analysis:

  • Examine CDC123 expression and eIF2 complex assembly in cancer tissues

  • Correlate with markers of translational dysregulation

  • Evaluate potential as diagnostic or prognostic marker

• Environmental Response Studies:

  • Monitor CDC123-mediated translational regulation during environmental stress responses

  • Analyze ATP-dependent translation control under energy-limiting conditions

  • Compare responses across species with different environmental adaptations

The discovery that CDC123 links ATP concentration to eIF2 complex assembly provides a mechanistic foundation for understanding how cells coordinate energy status with protein synthesis capacity across different biological contexts .